Clinical Study of Kangai Injection Combined with Chemotherapy in the Treatment of Advanced Lung Cancer
Zhang Cheng
Abstract
Zhang Cheng
Abstract
Objective To improve the patients with advanced lung cancer quality of life,reduce the chemotherapy-induced side effects,thereby enhancing immune function. Methods The treatment group Kangai injection 60 ml in 5% glucose or 0.9% NS 250~500 ml diluted intravenous drip,once/d,30 d for a course of treatment,combined with chemotherapy. The control group alone with chemotherapy. Results 47.5% effective in the treatment group,37.5% effective in the control group. Conclusion Kangai injection combined with chemotherapy can improve the quality of life of patients and reduce the toxicity,and enhance immune function in patients.
OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To improve the patients with advanced lung cancer quality of life,reduce the chemotherapy-induced side effects,thereby enhancing immune function. Methods The treatment group Kangai injection 60 ml in 5% glucose or 0.9% NS 250~500 ml diluted intravenous drip,once/d,30 d for a course of treatment,combined with chemotherapy. The control group alone with chemotherapy. Results 47.5% effective in the treatment group,37.5% effective in the control group. Conclusion Kangai injection combined with chemotherapy can improve the quality of life of patients and reduce the toxicity,and enhance immune function in patients.
Key concepts: Medicine, Chemotherapy, Lung cancer, Oncology, Internal medicine, Immune system, Toxicity, Quality of life (healthcare)